Diabetech
The latest in diabetes tech and research—and what it means for you
Connect
Dexcom's latest CGM is now supported on the Omnipod 5 iPhone App.
Tandem Diabetes is already telling patients its smartphone app to control the Mobi insulin pump will arrive by the end of 2025.
The diabetes division will separate from its parent company. Could this unlock faster innovation—or is it more of the same with a new name?
Major updates for diabetes apps have dropped, our latest podcast, and we've got a giveaway!
This early pioneer was certain CGM technology would improve patient lives when others doubted her.
After three years with Omnipod, a tubed pump taught me something new about tech—and myself
Tandem’s SteadiSet just received FDA 510(k) clearance—and it could soon bring 7-day wear to more insulin pump users.
Glucotrack is working on a 3-year CGM implant that measures glucose directly from the blood.
An exclusive behind-the-scenes tour of Medtronic’s unreleased implantable CGM and the early days of its pump innovation.
The switch from a tubeless to a tubed pump had its challenges.
Dexcom G7 integration is finally coming to the Omnipod 5 iPhone users.
A new frontier for metabolic health tracking — and what it could mean for the future of CGMs
